-
BBLG Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Bone Biologics (BBLG)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 4 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.03 mm |
Total shares | 2.83 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Hankey Don | 2.47 mm | $562.00 k |
Lind Global Fund II | 203.05 k | $319.00 k |
Intracoastal Capital | 110.12 k | $149.00 k |
IOI Ionic Ventures | 43.09 k | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jan 25 | Deina H Walsh | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.9678 | 27,055 | 26.18 k | 27,055 |
15 Jan 25 | Jeff Frelick | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.9678 | 54,110 | 52.37 k | 54,110 |
16 Oct 24 | Phillip Terry Meikle II | Non-Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.88 | 28,185 | 52.99 k | 28,185 |
16 Oct 24 | Phillip Terry Meikle II | Non-Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.88 | 9 | 16.92 | 9 |
17 Sep 24 | Bruce Stroever | Non-Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.73 | 30,713 | 53.13 k | 30,713 |